Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib + Cisplatin/Gemcitabine in Advanced Biliary Cancer
NCT02151084Phase 2Active, not recruiting
- Sponsor
- University Health Network
- Start
- Nov 2014
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib in biliary tract carcinoma (BTC), gallbladder carcinoma, sponsored by University Health Network. Started Nov 2014; status: active, not recruiting.
02
Drugs
selumetinib
03
Conditions
biliary tract carcinoma (BTC)gallbladder carcinoma
Beyond the preview
Go deeper on NCT02151084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151084.